Outstanding cancer researcher acknowledged

21/05/2020

Dr Ulf Schmitz, Head of the Centenary Institute’s Computational BioMedicine Laboratory has been recognised as an outstanding investigator in the field of cancer research, being awarded an NHMRC Investigator Grant.

The grant, which will support Dr Schmitz and his exploration of post-transcriptional gene regulation in cancer over the next five years, will commence in 2021.

“Healthy cells normally undergo regulatory processes that turn DNA into proteins but when this process becomes distorted cancer cells are formed. My research is to understand the bio-mechanisms that control this gene regulation activity. By improving our understanding of gene regulation and its role in cancer, we can offer new opportunities for better diagnosis, and treatment,” said Dr Schmitz.

The NHMRC Investigator Grant scheme supports the research programs of outstanding investigators at all career stages with funding as well as research support packages. Further information on the grants can be found on the NHMRC website here.

Information on Dr Schmitz and his research can be found here.

Latest News

Respiratory research leader elected as Fellow

The Centenary Institute's Professor Phil Hansbro has been elected as a Fellow of the prestigious European Respiratory Society.

COVID-19 research targets human enzymes

Centenary Institute researchers are examining the critical role of human enzymes and the coronavirus.

Biomarker signature found for TB infection

Centenary Institute researchers, together with other Australian collaborators, have uncovered a unique blood-based biomarker signature in individuals infected by TB.

 

News Topics

ALL NEWS

 


Sign up for our latest News